Nephros
NEPH
36 hedge funds and large institutions have $9.5M invested in Nephros in 2026 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
6% more funds holding
Funds holding: 34 → 36 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25.24% less ownership
Funds ownership: 49.01% → 23.77% (-25%)
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
76% less capital inflows, than outflows
Capital inflows: $3.38M | Capital outflows: $14.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Institute of Technology
Cambridge,
Massachusetts
|
+$1.38M |
| 2 |
Johns Hopkins University
Baltimore,
Maryland
|
+$750K |
| 3 |
Meritage Group
San Francisco,
California
|
+$692K |
| 4 |
Blackstone
New York
|
+$462K |
| 5 |
Jasper Ridge Partners
Menlo Park,
California
|
+$46.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wexford Capital
West Palm Beach,
Florida
|
-$13.5M |
| 2 |
CC
Cornerstone Capital
Palo Alto,
California
|
-$459K |
| 3 |
Navellier & Associates
Reno,
Nevada
|
-$191K |
| 4 |
De Lisle Partners
Poole,
United Kingdom
|
-$62.1K |
| 5 |
Renaissance Technologies
New York
|
-$25.6K |
NEPH Hedge Fund Activity: Q3 2026 in Review
36 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2026, worth a combined $9.5M — down 50% from $19M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NEPH positions and 6 closed out — a net gain of 2 holders — while 4 added to existing stakes and 10 trimmed.
The largest buyer was Massachusetts Institute of Technology, opening a new position worth an estimated $1.38M. The largest seller was Wexford Capital, cutting an estimated $13.5M.
- 36 institutional investors held Nephros (NEPH) as of Q3 2026, up from 34 in Q2 2026.
- Funds reported $9.5M of Nephros stock for Q3 2026, down 50% quarter-over-quarter.
- 8 funds opened new Nephros positions in Q3 2026 and 6 closed out, a net change of +2 holders.
- The largest Nephros buyer in Q3 2026 was Massachusetts Institute of Technology, an estimated $1.38M added.
- The largest Nephros seller in Q3 2026 was Wexford Capital, an estimated $13.5M sold.
Based on aggregated 13F filings for Q3 2026.